pocketful logo
Sunil Healthcare Ltd logo

Sunil Healthcare Ltd

NSE: BSE: 537253

61.97

(-1.01%)

Wed, 01 Apr 2026, 08:20 pm

Sunil Healthcare Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    63.55

  • Net Profit

    -1.42

  • P/B

    1.34

  • Sector P/E

    52.79

  • P/E

    0

  • EV/EBITDA

    11.31

  • Debt/Equity (Industry)

    2.29

  • Interest Cover (Industry)

    -1.64

  • ROCE (Industry)

    0

  • RONW (Industry)

    0

  • ROE

    -2.80

  • ROCE

    4.39

  • Debt/Equity

    1.27

  • EPS (TTM)

    2.78

  • Dividend Yield

    0

  • Book Value

    49.96

  • Interest Cover

    0.81

Analysis

all

thumbs up icon

Pros

  • Sunil Healthcare has been profitable on average in the past, therefore cash runway is not a concern.
  • Sunil Healthcare has been profitable on average in the past, therefore cash runway is not a concern.
  • Debt is well covered by operating cash flow (30.4%, greater than 20% of total debt).
  • Debt is covered by short term assets, assets are 1.4x debt.
  • Sunil Healthcare's cash and other short term assets cover its long term commitments.
thumbs up icon

Cons

  • Unable to evaluate Sunil Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Sunil Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • Sunil Healthcare's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • The level of debt compared to net worth has increased over the past 5 years (82.8% vs 107.7% today).
  • Sunil Healthcare's level of debt (107.7%) compared to net worth is high (greater than 40%).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters73.5373.5373.5373.5373.53
FII00000
DII0.100.100.100.100.10
Public26.3726.3726.3726.3726.37
Government00000

Read More

Technical Analysis

RSI

43.43

MACD

-1.35

50 DMA

66.22

200 DMA

74.00

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic86.6675.0668.5163.4656.9151.8640.26
Fibonacci75.0670.6367.8963.4659.0356.2951.86
Camarilla65.1664.1063.0363.4660.9159.8458.78

Pivots Level: Classic

R3

+23.20

86.66

R2

+11.60

75.06

R1

+5.06

68.51

63.46
63.46
Pivot Point
LTP: 61

S1

-6.54

56.91

S2

-11.60

51.86

S3

-23.20

40.26

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    62.60

  • 20-EMA

    63.64

  • 30-EMA

    64.50

  • 50-EMA

    65.87

  • 100-EMA

    68.47

  • 200-EMA

    71.49

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
06 Feb 2026board-meetingsQuarterly Results, Nine Months Results
04 Nov 2025board-meetingsQuarterly Results
30 Jul 2025agm
16 Sept 2024agm
12 Aug 2023agm
20 Jul 2022agm
21 Jul 2021agm

Read More

Peer Comparison

Sunil Healthcare Ltd logo

Sunil Healthcare Ltd

Aster DM Healthcare Ltd logo

Aster DM Healthcare Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Read More

Sunil Healthcare Ltd About

Sunil Healthcare has manufacturing plant in Alwar (Rajasthan), India. The Group is a manufacturer of Empty Hard Gelatin, HPMC Capsule Shells.

Industry

Miscellaneous

Founded

1973

Headquarters

CEO

Anil Kumar Khaitan

Employees

Contact

Website icon

Website

http://www.sunilhealthcare.com

Email icon

Email

info@sunilhealthcare.com; virendra.garg@sunilhealt

Phone icon

Phone

91-11-49435555

Location icon

Location

38E/252-A 1st Flr, Vijay Tower Shahpurjat, New Delhi, New Delhi, 110049

Read More

Sunil Healthcare Ltd Company History

YearHistory
1976
  • Sunil Healthcare Ltd was established.
2014
  • Sunil Healthcare Ltd shares were listed and admitted to dealings on the Exchange
  • Sunil Healthcare Limited received the award for 'Outstanding Contribution to India's Pharmaceutical Exports' for the year FY 2012-2013.
2015
  • ICRA upgraded the long-term rating of Sunil Healthcare to BBB
  • Sunil Healthcare Ltd received the 'Award for the Best Use of Six Sigma in Healthcare' by ABP News.
2016
  • Sunil Healthcare set up a wholly owned subsidiary in the USA, named Sunil Healthcare North America LLC.
2017
  • The company's Food Division was awarded the prestigious 'Export Award' as 'Top Most Exporter under Cashew nut and Allied products from New Delhi.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
SHAILESH KUMARBuy6400097.3302 May 2024
QOPPA TRADING PRIVATE LIMITEDSell5181691.116 Dec 2015
ESQUIRE ENGINEERING LTDSell27469645.0115 Sept 2015
KANCHAN SUNIL SINGHANIABuy29452945.1815 Sept 2015

Read More

Sunil Healthcare Ltd News

Sunil Healthcare Q3 FY26 Results Announced

Sunil Healthcare Limited announced Q3 FY26 financial results with standalone revenue of ₹2,183.73 lakhs and net profit of ₹44.30 lakhs for the quarter ended December 31, 2025.

06 Feb 2026

co actions results

Sunil Healthcare Reports Q2 FY2026 Financial Results with Mixed Performance

Sunil Healthcare Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2025. The company's standalone revenue from operations was Rs. 235.76 lakhs for Q2 compared to Rs. 226.20 lakhs in the previous quarter. For the half-year period, standalone revenue reached Rs. 461.96 lakhs versus Rs. 437.52 lakhs in the corresponding previous period. The company reported a standalone profit after tax of Rs. 7.90 lakhs for Q2, while the consolidated results showed a loss after tax of Rs. 5.64 lakhs for the same quarter. On a half-yearly basis, standalone profit after tax was Rs. 50.75 lakhs, while consolidated operations recorded a loss of Rs. 18.47 lakhs. The Board meeting was held on November 4, 2025, and the results were approved along with limited review reports from auditors.

04 Nov 2025

earnings

Sunil Healthcare Approves Q1 FY2025-26 Results and Sets AGM Date for September 29, 2025

Sunil Healthcare Limited's Board of Directors held their 264th meeting on July 30, 2025, approving unaudited standalone and consolidated financial results for Q1 FY2025-26 ended June 30, 2025. The company reported revenue from operations of Rs. 2,254.20 lakhs and profit after tax of Rs. 28.62 lakhs for the quarter. The Board scheduled the 51st Annual General Meeting for September 29, 2025, to be conducted through video conferencing at the company's registered office in New Delhi. Book closure period was fixed from September 23-29, 2025, with September 22, 2025 as the cut-off date for voting entitlements. The company appointed MUFG Intime India Private Limited for e-voting and video conferencing services, and ATCS & Associates as scrutinizer for the AGM e-voting process.

30 Jul 2025

corporate action

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800